Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Agnosia 6Pain 5Breast Neoplasms 5Pain, Postoperative 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Postoperative Nausea and Vomiting 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Chronic Pain 1Cancer Pain 1

Interventions

Fentanyl 3Sodium Chloride 2Pregabalin 2Morphine 2Mindfulness-Based Stress Reduction 2Ketamine 2Hypnosis 2Dexmedetomidine 2Bupivacaine 2Anesthetics, Local 2tianeptine 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1Therapeutics 1Telemedicine 1Tea 1Surveys and Questionnaires 1Spinal Cord Stimulation 1Ropivacaine 1Plastic Surgery Procedures 1Nerve Block 1Mindfulness-Based Cognitive Therapy 1Mindfulness 1Methadone 1Meloxicam 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1Exercise Therapy 1Epinephrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Chronic Pain × Analgesics, Opioid × Clear all
NCT01541124 2018-02-08

Morphine as First Drug for Cancer Pain

Federal University of São Paulo

Phase NA Completed
60 enrolled

Cancer Pain, Agnosia, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡